Percorrer por autor "Blesl, A."
A mostrar 1 - 2 de 2
Resultados por página
Opções de ordenação
- Fidaxomicin for Clostridiodes difficile infection in inflammatory bowel disease: a multicenter retrospective cohort studyPublication . Noviello, D.; Chaparro, M.; Viganò, C.; Blesl, A.; Barberio, B.; Yanai, H.; Macaluso, F.; Iglesias, R. Ferreiro; Bezzio, C.; Zilli, A.; Molnár, T.; Gheorghe, C.; Conforti, F. S.; Innocenti, T.; Saibeni, S.; Bossuyt, P.; Oliveira, R. F. de; Gabrielli, A. M. Carvalhas; Losco, A.; Vieujean, S.; Tettoni, E.; Pirola, L.; Calderone, S.; Cohen, M. Kornowski; Dragoni, G.; Rath, T.; Acosta, M. Barreiro-de; Savarino, E. V.; Gisbert, J. P.; Vecchi, M.; Atreya, R.; Caprioli, F.Inflammatory bowel disease (IBD) patients with Clostridiodes difficile Infection (CDI) are at increased risk of disease exacerbations, therapy escalation, colectomy, and mortality. Data on fidaxomicin use in IBD patients with CDI are very limited. We aimed to assess the effectiveness and safety of fidaxomicin for CDI and its impact on IBD outcomes in a large retrospective multicenter cohort study
- Maintaining remission after an episode of steroid-responsive acute severe ulcerative colitis: what is the best strategy?Publication . Bravo, C.; Gomes, C. Frias; Blesl, A.; Damasceno, J.; Drygiannakis, I.; Argyriou, K.; Festa, S.; Aratari, A.; Todeschini, A.; Jelakovic, M.; Kani, H. Tarik; Idrees, Z.; Feijó, D.; Chaves, C.; Bacsur, P.; Michalopoulos, G.; Turcan, S.; Nardone, O. M.; Spyridon, V.; Bernardi, A. De; Nagmeldin, I.; Denjagic, M. Basic; Ribaldone, D. Giuseppe; Ploutarchos, P.; Karakan, T.; Oliveira, R.; Balestrieri, P.; Lopes, S.; Vasilakis, T.; Taelman, T.; Neri, B.; Clarke, M.; Mocci, G.; Kiudelis, G.; Vieujean, S.; Sciberras, N.; Milenkovic, Z.; Bonazzi, E.; Karmiris, K.; Torres, J.The best maintenance therapy after a steroid-responsive acute severe ulcerative colitis (ASUC) episode remains poorly studied and is not addressed in current guidelines. We aimed to compare the impact of different treatment strategies following hospitalization for steroid-responsive ASUC.
